Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
1 - 10 out of 507Page size: 10
Sort by: 1st author
  1. Published

    Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease

    Adrian, T., Hornum, Mads, Knop, Filip Krag, Christensen, Karl Bang, Almdal, Thomas Peter, Rossing, Peter, Lídaa, L. Í., Heinrich, N. S., Boer, V. O., Marsman, A., Petersen, E. T., Siebner, Hartwig Roman & Feldt-Rasmussen, Bo, 2023, In: Nephron. 147, 11, p. 673–684 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Adrian, T., Hornum, Mads, Knop, Filip Krag, Almdal, Thomas Peter, Rossing, Peter, Lida, L., Heinrich, N. S., Boer, V. O., Marsman, A., Petersen, E. T., Siebner, Hartwig Roman & Feldt-Rasmussen, Bo, 2023, In: Nephron. 147, 6, p. 317–328

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Preventing Early Renal Loss in Diabetes (PERL) study: A randomized double-blinded trial of allopurinoldrationale, design, and baseline data

    Afkarian, M., Polsky, S., Parsa, A., Aronson, R., Caramori, M. L., Cherney, D. Z., Crandall, J. P., De Boer, I. H., Elliott, T. G., Galecki, A. T., Goldfine, A. B., Sonya Haw, J., Hirsch, I. B., Karger, A. B., Lingvay, I., Maahs, D. M., McGill, J. B., Molitch, M. E., Perkins, B. A., Pop-Busui, R. & 14 others, Pragnell, M., Rosas, S. E., Rossing, Peter, Senior, P., Sigal, R. J., Spino, C., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Weinstock, R. S., Wu, C., Mauer, M., Doria, A. & PERL Study Group, P. S. G., 2019, In: Diabetes Care. 42, 8, p. 1454-1463

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes

    Afshinnia, F., Rajendiran, T. M., He, C., Byun, J., Montemayor, D., Darshi, M., Tumova, J., Kim, J., Limonte, C. P., Miller, R. G., Costacou, T., Orchard, T. J., Ahluwalia, Tarun Veer Singh, Rossing, Peter, Snell-Bergeon, J. K., de Boer, I. H., Natarajan, L., Michailidis, G., Sharma, K. & Pennathur, S., 2021, In: Diabetes Care. 44, 9, p. 2098-2106 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

    Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L. M., Boletis, J., Toto, R., Umpierrez, G. E., Wanner, C., Wada, T., Scott, C., Joseph, A., Ogbaa, I., Roberts, L., Scheerer, M. F., Bakris, G. L. & FIDELIO-DKD Investigators, F. I., 2022, In: Nephrology Dialysis Transplantation. p. 1261–1269 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone

    Agarwal, R., Anker, S. D., Bakris, G., Filippatos, G., Pitt, B., Rossing, Peter, Ruilope, L., Gebel, M., Kolkhof, P., Nowack, C., Joseph, A. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 6, p. 1014–1023

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

    Agarwal, R., Pitt, B., Rossing, Peter, Anker, S. D., Filippatos, G., Ruilope, L. M., Kovesdy, C. P., Tuttle, K., Vaduganathan, M., Wanner, C., Bansilal, S., Gebel, M., Joseph, A., Lawatscheck, R. & Bakris, G. L., 2023, In: JAMA Cardiology. 8, 8, p. 732-741 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

    Agarwal, R., Ruilope, L. M., Ruiz-Hurtado, G., Haller, H., Schmieder, R. E., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Lambelet, M., Nowack, C., Kolkhof, P., Joseph, A. & Bakris, G. L., 2023, In: Journal of Hypertension. 41, 2, p. 295-302 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: The FIDELITY pooled analysis

    Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M. & Bakris, G. L., 2022, In: European Heart Journal. 43, 6, p. 474-484 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

    Agarwal, R., Pitt, B., Palmer, B. F., Kovesdy, C. P., Burgess, E., Filippatos, G., Małyszko, J., Ruilope, L. M., Rossignol, P., Rossing, Peter, Pecoits-Filho, R., Anker, S. D., Joseph, A., Lawatscheck, R., Wilson, D., Gebel, M. & Bakris, G. L., 2023, In: Clinical Kidney Journal. 16, 2, p. 293-302 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...51 Next

ID: 12937790